AzTrials
AzTrials

Pregnancy RelatedNCT05494268

Effects of Preoperative Oral Carbohydrate Loading on Maternal Thiol-disulfide Homeostasis

An observational study of Pregnancy Related and Cesarean Delivery Affecting Fetus, run by Karamanoğlu Mehmetbey University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary aim of this randomised control trial is to assess the impact of pre-operative carbohydrate loading on thiol disulfide homeostasis when compared to standard care in elective cesarean section. Half of the participants will receive pre-operative carbohydrates and the other half will receive standard care. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
What is being tested?
Carbohydrate
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
13 Sep 2022to 5 Nov 2022
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: The term pregnant patients admitted to Karaman Training and Research Hospital

Who may be able to join

  • Term pregnancies,
  • Planned elective ceserean sections,
  • Under spinal anesthesia,
  • Pregnants who can read and write Turkish.

Who cannot join

  • Preterm pregnants,
  • Pregnants with reflux,
  • obesity,
  • hiatus hernia,
  • ileus,
  • enteral nutrition,
Show all 13Show fewer
  • alcohol or substance abuse,
  • prolonged delivery,
  • systemic chronic diseases,
  • malignancy,
  • GDM,eclampsia,preeclampsia,
  • fetal anomaliy,
  • prolonged delivery

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Karaman Training and Research Hospital

    Karaman, Merkez, 70200

Other trials in Turkey (Türkiye)

About this study

The primary aim of this randomised control trial is to assess the impact of pre-operative carbohydrate loading on thiol disulfide homeostasis when compared to standard care in elective cesarean section. Half of the participants will receive pre-operative carbohydrates and the other half will receive standard care.

Read the detailed description

The concept of enhanced recovery after surgery (ERAS) has been gradually extended from surgery to the field of obstetrics. Carbohydrate loading before the surgery in obstetric patients reduce the incidence of nausea and vomiting and reduce insulin resistance. Although these effects of the preoperative carbohydrate loading has been studied, the thiol disulfide homeostasis effects after carbohydrate loading has not been investigated yet. Thiol-disulfide homeostasis (TDH) plays a critical role in the mechanisms of antioxidant defense, detoxification, apoptosis, regulation of enzyme activities, transcription, and cellular signal transduction. Since the newborns are very susceptible to harmfull effects of reactive oxygen species, the effect of carbohydrate loading on the reactive oxygen species gain importance.

All mothers undergoing a planned caesarean section in the Karaman Training and Research Hospital will be invited to participate. Mothers will be divided into two groups. One group will receive standard care and the other group will receive a carbohydrate drink in addition to standard care.

Being tested
Carbohydrate
Medical subject headings
Fetus-in-Fetu

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CarbohydrateDrug

    Preoperative Carbohydrate Loading Drink

Study groups in NCT05494268
Study groupRoleWhat they receive
Experimental ( Carb Group)Preoperative education will be provided by researchers to the patients on the ward before fluid intake. Solid food will be forbidden starting at 20:00 p.m, and drinking will be forbidden after 22:00 p.m the day before surgery. The Carb Group will consume carbohdrate fluid and Non-carb Group will consume equal amount of water at night and two hours before the surgery.
Receives: Drug: Carbohydrate
Standart Care (Non-carb Group)Preoperative education will be provided by researchers to the patients on the ward before fluid intake. Solid food will be forbidden starting at 20:00 p.m, and drinking will be forbidden after 22:00 p.m the day before surgery. The Carb Group will consume carbohdrate fluid and Non-carb Group will consume equal amount of water at night and two hours before the surgery.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The comparison of the changes in thiol disulfide values between the groups

    The native thiol, total thiol, disulfide, native thiol/total thiol ratio, disulfide/native thiol ratio, and disulfide/total thiol ratio will be determined.

    Measured: From beginning to two hours after the surgery

Secondary outcomes (2)
  1. Incidence of intraoperative hypotension

    Hypotension is defined as a decrease in the mean arterial pressure by ˃20% of the baseline value.

    Measured: From beginning to the end of the surgery

  2. Total ephedrine usage

    At hypotensive episodes, 5 mg ephedrine will be used intravenously.

    Measured: From beginning to the end of the surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2022
  2. Study start13 Sep 2022
  3. Primary completion30 Oct 2022
  4. Study completion5 Nov 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
80 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT05494268
Sponsor's protocol ID
KaramanogluMehmeybeyU
Status last verified
Dec 2022
First submitted
6 Aug 2022
Last updated
19 Dec 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: All the results of the study will be shared on request.

Questions about this trial

What is this clinical trial studying?

An observational study of Pregnancy Related and Cesarean Delivery Affecting Fetus, run by Karamanoğlu Mehmetbey University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The comparison of the changes in thiol disulfide values between the groups (time frame: From beginning to two hours after the surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in